SPY334.03+1.92 0.58%
DIA273.71+1.71 0.63%
IXIC11,104.09+105.69 0.96%

Vertex Pharmaceuticals are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company raised FY20 sales guidance.

Benzinga · -